SCCS for Detection of Differences in Brand and Generic Adverse Drug Events.
Publication
, Conference
Badger, JC; LaRose, ER; Kleiman, R; Berg, RL; Linneman, JG; Hansen, R; Page, D; Peissig, PL
Published in: CRI
2017
Duke Scholars
Published In
CRI
Publication Date
2017
Publisher
AMIA
Citation
APA
Chicago
ICMJE
MLA
NLM
Badger, J. C., LaRose, E. R., Kleiman, R., Berg, R. L., Linneman, J. G., Hansen, R., … Peissig, P. L. (2017). SCCS for Detection of Differences in Brand and Generic Adverse Drug Events. In CRI. AMIA.
Badger, Jonathan C., Eric R. LaRose, Ross Kleiman, Richard L. Berg, James G. Linneman, Richard Hansen, David Page, and Peggy L. Peissig. “SCCS for Detection of Differences in Brand and Generic Adverse Drug Events.” In CRI. AMIA, 2017.
Badger JC, LaRose ER, Kleiman R, Berg RL, Linneman JG, Hansen R, et al. SCCS for Detection of Differences in Brand and Generic Adverse Drug Events. In: CRI. AMIA; 2017.
Badger, Jonathan C., et al. “SCCS for Detection of Differences in Brand and Generic Adverse Drug Events.” CRI, AMIA, 2017.
Badger JC, LaRose ER, Kleiman R, Berg RL, Linneman JG, Hansen R, Page D, Peissig PL. SCCS for Detection of Differences in Brand and Generic Adverse Drug Events. CRI. AMIA; 2017.
Published In
CRI
Publication Date
2017
Publisher
AMIA